Ranbaxy spinout gets $6.5M for N.J.-based generics biz
Bionpharma just raised $6.5 million, according to a regulatory filing - on top of about $31 million raised last year.
Bionpharma just raised $6.5 million, according to a regulatory filing - on top of about $31 million raised last year.